コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 GI adverse events occurred in 42 patients (41%) after a
2 GI bleeding can also occur in patients affected by acqui
3 GI bleeding was the leading presentation in immunocompet
4 GI bleeding was the most common presentation.
5 GI cancers account for 26% of the global cancer incidenc
6 GI complications, including bowel distension, diarrhea,
7 GI events, reported in 97 patients (62%), were predomina
8 GI symptom severity (GSRS-IBS), and anxiety and depressi
9 GI symptoms were grouped into four categories, abdominal
10 GI was associated with CHD risk only in the continuous m
11 GI-CMV infection was frequently observed among immunocom
12 GI.1 Lot 001-09NV appears to be similar in virulence to
13 GI.1-specific cellular responses in peripheral blood wer
15 iment core around Greenland Interstadial 10 (GI-10) ~41 ka BP and the Laschamp geomagnetic excursion.
16 year incidence of late RT-related grade >= 3 GI (2.5% v 3.9%) or genitourinary toxicity (2.9% v 2.9%)
19 ts with advanced-stage CRC.Keywords: Abdomen/GI, CT, Comparative Studies, Large BowelSupplemental mat
20 ic protocol dual-energy CT.Keywords: Abdomen/GI, CT, CT-Dual Energy, CT-Quantitative, PancreasSupplem
21 acterized as category LR-M.Keywords: Abdomen/GI, Evidence Based Medicine, Liver, Neoplasms-Primary, U
25 creening revealed broad-spectrum activities (GI(50): 1.43-2.09 muM) and 17d had a remarkable selectiv
29 VIII concentrates is generally started after GI-bleeding events, but this therapy is not always succe
32 of RB1 leads to profound nuclear defects and GI generating aberrant cytoplasmic DNA, however simultan
33 nd January 2018, patients seen in the ED and GI clinic of Loghman Hakim Hospital with unexplained abd
34 ts seen in the Laghman Hakim Hospital ED and GI clinic who were lead-intoxicated, with or without opi
36 ircadian clock assays revealed that ELF3 and GI are essential that enable the oscillator to synchroni
38 single loss of function mutants of ELF3 and GI have been well studied, their genetic interaction rem
40 lacking both genes, suggesting that ELF3 and GI together convey photoperiod sensing to the central os
43 lectivity studies, the NCI60 cell-panel, and GI(50) determinations for several cancer cell lines.
51 rsus 1.47 +/- 1.76 mm; test versus control), GI reduction (-1.14 +/- 1.15 versus -1.04 +/- 0.89; test
54 rtificial intelligence-based medical device (GI-Genius, Medtronic) trained to process colonoscopy ima
55 tions, including bowel distension, diarrhea, GI bleeding and ileus, were evaluated during the first 3
56 this study was to determine whether dietary GI, GL, and available carbohydrates are associated with
58 Proteolysis was highly affected by elderly GI alterations (p < 0.05) (50% of reduction compared to
60 mmalian paralog gene pairs reveals extensive GIs and uncovers phenotypes normally masked by functiona
63 nchanged after the introduction of FilmArray GI panel, but length of hospital stay was shorter (3 vs.
66 t common pathogens detected by the FilmArray GI panel were Clostridium difficile (55.0%), Campylobact
67 presents an effective screening approach for GI mapping and the functional analysis of sizable genomi
68 hat perform functions that are important for GI health, nutrient harvest and growth hormone signaling
69 culation, and fecal shedding as a marker for GI colonization, we showed that K. pneumoniae can asympt
70 Stool specimens were tested by RT-qPCR for GI and GII noroviruses and subsequently genotyped by seq
75 howed reduced fitness in a gastrointestinal (GI) colonization model, yet induced greater damage to ep
80 nd no associations between gastrointestinal (GI) symptoms and combined low disaccharidase activity.
81 ess is severely limited by gastrointestinal (GI) tract toxicity caused by gut bacterial beta-glucuron
82 characteristics of the CF gastrointestinal (GI) tract, including inflammation, maldigestion and mala
84 udy was to identify common gastrointestinal (GI) symptom groups using the Patient-Reported Outcomes M
85 fecal SCFA concentration, gastrointestinal (GI) symptoms, dietary intake, and quality of life were m
86 teroceptive cortex, during gastrointestinal (GI) malaise, a state akin to the emotion of disgust in h
87 lyze the effect of elderly gastrointestinal (GI) conditions on proteolysis, lipolysis and calcium and
89 re particularly robust for gastrointestinal (GI) cancers, such as those affecting the GI tract, liver
90 ion of NIR-II emitters for gastrointestinal (GI) tract imaging remains challenging due to fluorescenc
91 er-metabolism in the human gastrointestinal (GI) tract and respiratory system are largely unknown and
96 d 4.8 million new cases of gastrointestinal (GI) cancers and 3.4 million related deaths, worldwide, i
98 inked to the disruption of gastrointestinal (GI) tract epithelial barrier integrity and subsequent mi
100 ed in the modelling of the gastrointestinal (GI) absorption of drugs and in oral drug development.
101 intain the function of the gastrointestinal (GI) epithelium are critical for health and survival of m
104 phil infiltration into the gastrointestinal (GI) tract and is characterized by various digestive symp
107 hways mutation rate in the Gastrointestinal (GI) tract cancers in a systematic review and meta-analys
108 zed by inflammation of the gastrointestinal (GI) tract, and it is associated with different neurologi
109 yos, adult brains, and the gastrointestinal (GI) tract, and many cancers, including epithelial GI tum
110 imarily synthesized in the gastrointestinal (GI) tract, where it is secreted into the lumen and subse
113 ed for 24 hours, and then, gastrointestinal (GI) tissues were collected for histological examination.
115 otential is limited due to gastrointestinal (GI) syndrome, elucidation of the regenerative response f
116 acquisition, we assessed the kinetics of GBS GI colonization, progression to invasive disease, and th
117 ty of different disaccharidases with general GI symptom presentations in a large cohort of pediatric
118 f the Arabidopsis circadian clock, GIGANTEA (GI) and ZEITLUPE (ZTL), which likely act as compensatory
120 es not support an association between a high GI and GL in midpregnancy and increased offspring risk o
127 edictability of drug absorption in the human GI tract than a Caco-2 Transwell system (Spearman's corr
128 st groups resulted in significant changes in GI and BOP at Day 42 compared to control and un-flossed
129 e found no evidence of global differences in GI between domestic and wild canids, certain regional di
130 for the first time found to be expressed in GI crypt cells, and SHP2 expression in the crypt Osx+ ce
131 strated significantly greater improvement in GI and IPS from baseline (p < 0.01) and greater efficacy
132 ing titers (BT50) and a 161-fold increase in GI.1-specific immunoglobulin (Ig)G titers when compared
133 y variable, 2) most somatic L1 insertions in GI cancer tissues are absent from normal tissues, and 3)
134 the accuracy of Ki-67 index quantitation in GI-NETs: (1) Synaptophysin-KI-Estimator (SKIE), a pipeli
135 lity, showing >50-fold higher sensitivity in GI tract, and migrated homogenously during gastrointesti
137 obustness of TC through natural variation in GI and ZTL alleles found on the Cape Verde Islands.
138 robing depth (PD) >=4 mm and gingival index (GI) >=1 at >=4 sites distributed over >=2 anterior teeth
140 attachment level (CAL), and gingival index (GI) were performed by calibrated masked examiners for up
141 ental plaque score (IPS) and gingival index (GI) were recorded at baseline and 4-week post-usage.
142 lifestyle intervention (low glycaemic index (GI) diet plus physical activity) in pregnant women with
143 s indicate that high dietary glycemic index (GI) and glycemic load (GL) are associated with increased
144 between midpregnancy dietary glycemic index (GI), glycemic load (GL), and sugar-sweetened beverages a
145 luate the nutritional value, glycemic index (GI), total phenol content (TPC), and total flavonoid con
146 surface, we compared the gyrification index (GI) in 19 carnivore species, including six wild canid an
147 vel (CAL), gingival recession, plaque index, GI, and bleeding on probing (BOP) were recorded at basel
149 the rate of change in gingival inflammation (GI) was dramatically different between the APE test grou
150 ctivated by hypoglycemia (glucose-inhibited [GI] neurons) have been assumed to play a critical althou
152 staining both proteome and genome integrity (GI) requires the integration of a wide range of mechanis
153 Systematic mapping of genetic interactions (GIs) and interrogation of the functions of sizable genom
155 a foundation for new avenues of inquiry into GI stem cell biology and of OSTERIX's therapeutic and di
156 ro and in vivo stability of genomic islands (GIs), integrative conjugative elements (ICEs), and proph
158 plored correlations between global and local GI with brain mass, cortical thickness, white and gray m
164 conventional HMT in the development of lower GI, higher value-added functional starch foodstuffs.
168 estigated the global burden from the 5 major GI cancers, as well as geographic and temporal trends in
169 e, attack rate, and duration of illness make GI.1 Lot 001-09NV a useful challenge strain for future v
170 is a prognostic factor for survival in many GI cancers, there is limited knowledge regarding its imp
172 t breads may serve as products with a medium GI, as a source of TPC, and as products with a high AC.
174 ignificantly higher in the Mild and Moderate GI symptom groups, and they indicated significantly lowe
177 uctuations, being glucose-inhibited neurons (GI-ERalpha(vlVMH)) or glucose-excited neurons (GE-ERalph
179 -negative bacteria, is present in the normal GI tract and levels increase during high-fat feeding and
183 n of the Cape Verde Islands (Cvi) alleles of GI and ZTL into the Landsberg erecta (Ler) background, w
187 Additionally, molecular characterization of GI (Cvi) reveals a novel functional motif that can modul
189 is a promising target for the development of GI tract therapies, yet it has been under-exploited due,
190 oit cross-species information in the form of GI data across multiple species, and arbitrary side info
191 bdominal pain and have a unique frequency of GI symptoms due to low frequency of diarrhea and weight
194 dy, we aimed to investigate the incidence of GI complications and their influence on prognosis of hos
195 Is for a CHD event, in relation to intake of GI, GL, and carbohydrates, were estimated using covariat
202 tional Study, investigating the relations of GI, glycemic load, other carbohydrate measures (added su
204 t chimney was associated with higher risk of GI cancers combined (10-y HR: 1.05; 95% CI: 1.00, 1.11),
209 on advances in mechanistic understanding of GI physiology coupled with novel ingestible technologies
210 e providers evaluate individual patterns of "GI health" when young adults present with anxiety and de
215 114 (11%) patients experienced at least one GI complication and diarrhea (5.2%) was the most common.
216 ults surveyed were experiencing at least one GI symptom of a severity greater than normative levels.
217 network measures and IBS symptom severity or GI-specific anxiety but we found a significant differenc
223 cally handled system that uses large porcine GI tissue explants that are functionally maintained for
224 , n = 163) and from June 2016-May 2017 (post-GI PCR, n = 182) and followed them for 1 year after tran
226 C. difficile diarrheal pathogens in the post-GI PCR cohort were enteropathogenic Escherichia coli (n
227 received an HCT from June 2014-May 2015 (pre-GI PCR, n = 163) and from June 2016-May 2017 (post-GI PC
229 he maximal inhibition of cell proliferation (GI(50)) in the low micromolar range in the PC3 cell line
231 e ages of 18 and 25 who completed the PROMIS-GI as part of ongoing research monitoring physical and p
233 It is clear that BMP signaling regulates GI function and disease progression that involve stem/pr
234 immune checkpoint inhibitor therapy-related GI adverse events in patients with cancer and inflammato
237 delta(17)O = -2.92 +/- 0.79 per mille (SD)), GI fluid (GF; deltaD = -35.91 +/- 7.30 per mille (SD), d
239 Preexisting IBD increases the risk of severe GI adverse events in patients treated with immune checkp
244 ed Outcomes Measurement Information System - GI symptom scales (PROMIS-GI) within a large sample of y
250 the time of maximum plaque accumulation, the GI of the APE test group was a 109% greater than the GI
251 al (GI) cancers, such as those affecting the GI tract, liver, and pancreas, on which this review is f
253 pneumoniae can asymptomatically colonize the GI tract in immunocompetent mice and modifies the host G
254 complex, large mucosal-based lesions in the GI tract using standard endoscopic equipment and a novel
255 cretion and visceral hypersensitivity in the GI tract, and has been implicated in diseases such as ir
256 a cytokine that mediates inflammation in the GI tract, but the transcriptional program that governs G
258 novel functional motif that can modulate the GI/ZTL interaction as well as nucleocytoplasmic partitio
259 emonstrate that during the disruption of the GI tract and increased microbial translocation, we find
270 e APE test group was a 109% greater than the GI of the test group (P <= 0.001) despite similar plaque
273 sentation and pathological damage within the GI tract, positioning GM-CSF as a key regulator of GVHD
275 e genome of V. cholerae to remove all of the GIs, ICEs, and prophages and revealed important interact
278 and treatment-related factors in addition to GI and genitourinary baseline function, with higher scor
279 sulted in high-magnitude fire peaks close to GI/GS boundaries, even exacerbated by local peatland con
280 ubjects developed strong immune responses to GI.1 with a 30-fold (geometric mean titer) increase in b
281 lic alterations, increased susceptibility to GI disease, and a system-wide recalibration of immune co
284 Netherlands, using data from the Dutch Upper GI Cancer Audit (DUCA) for transthoracic esophagectomy.
285 All patients registered in the Dutch Upper GI Cancer Audit who underwent potentially curative esoph
286 count < 50 x 10(9) /L) and nonvariceal upper GI bleed (diagnosed after doing upper gastrointestinal e
287 osis with coagulopathy and nonvariceal upper GI bleeding, TEG-guided transfusion strategy leads to a
288 international multicenter study by the Upper GI International Robotic Association (UGIRA) aimed to ga
289 inis obtained from patients undergoing upper GI cancer surgery compared with controls (N = 30; n = 1,
290 abinoids as anecdotal treatments for various GI disorders inspired the search for mechanisms by which
291 drug screen and showed potent activity with GI(50) values reaching the nanomolar level, with mean gr
293 haridase combinations may be associated with GI symptoms in subjects; a prospective study may be need
296 ctive study included patients diagnosed with GI-CMV infection at Siriraj Hospital (Bangkok, Thailand)